These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7992237)

  • 21. Single-chain factor XII exhibits activity when complexed to polyphosphate.
    Engel R; Brain CM; Paget J; Lionikiene AS; Mutch NJ
    J Thromb Haemost; 2014 Sep; 12(9):1513-22. PubMed ID: 25039405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.
    Bernardo MM; Day DE; Halvorson HR; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12477-83. PubMed ID: 8509387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions.
    Shore JD; Day DE; Bock PE; Olson ST
    Biochemistry; 1987 Apr; 26(8):2250-8. PubMed ID: 3113477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The autoactivation of factor XII in the presence of long-chain saturated fatty acids--a comparison with the potency of sulphatides and dextran sulphate.
    Mitropoulos KA; Esnouf MP
    Thromb Haemost; 1991 Oct; 66(4):446-52. PubMed ID: 1796394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible basis for the apparent surface selectivity of the contact activation of human blood coagulation factor XII.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1986 Oct; 25(21):6688-94. PubMed ID: 3491625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage.
    Citarella F; Wuillemin WA; Lubbers YT; Hack CE
    Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII: Hageman factor.
    Pixley RA; Colman RW
    Methods Enzymol; 1993; 222():51-65. PubMed ID: 8412813
    [No Abstract]   [Full Text] [Related]  

  • 30. An insight into the biophysical characterization of different states of cefotaxime hydrolyzing β-lactamase 15 (CTX-M-15).
    Rehman MT; Faheem M; Khan AU
    J Biomol Struct Dyn; 2015; 33(3):625-38. PubMed ID: 24650131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of conformational change in complement factor 3 and factor XII adsorbed to acrylate polymers is related to a high degree of polymer backbone flexibility.
    Fromell K; Yang Y; Nilsson Ekdahl K; Nilsson B; Berglin M; Elwing H
    Biointerphases; 2017 Jun; 12(2):02D417. PubMed ID: 28637352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purified factor XII has a higher specific activity than the parent molecule in plasma.
    Wuillemin WA; Furlan M; Huber I; Lämmle B
    Thromb Haemost; 1991 Feb; 65(2):169-73. PubMed ID: 2053104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amidolytic properties of single-chain activated Hageman factor.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1461-3. PubMed ID: 286331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational transitions of cinnamoyl CoA reductase 1 from Leucaena leucocephala.
    Sonawane PD; Khan BM; Gaikwad SM
    Int J Biol Macromol; 2014 Mar; 64():30-5. PubMed ID: 24309513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and conformational transitions of mevalonate diphosphate decarboxylase from Bacopa monniera.
    Abbassi S; Patel K; Khan B; Bhosale S; Gaikwad S
    Int J Biol Macromol; 2016 Feb; 83():160-70. PubMed ID: 26657583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mimicking lipid-binding-induced conformational changes in the human apolipoprotein E N-terminal receptor binding domain effects of low pH and propanol.
    Clément-Collin V; Leroy A; Monteilhet C; Aggerbeck LP
    Eur J Biochem; 1999 Sep; 264(2):358-68. PubMed ID: 10491080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.